A Randomized, Multicenter, Double-Blind, Parallel-Group Study to Assess the Efficacy and Safety of Impracor (Ketoprofen 10% Cream) Compared With Placebo in the Treatment of Acute Pain (Flare) Associated With Osteoarthritis of the Knee

Trial Profile

A Randomized, Multicenter, Double-Blind, Parallel-Group Study to Assess the Efficacy and Safety of Impracor (Ketoprofen 10% Cream) Compared With Placebo in the Treatment of Acute Pain (Flare) Associated With Osteoarthritis of the Knee

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 12 Nov 2013

At a glance

  • Drugs Ketoprofen (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 12 Nov 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 12 Aug 2013 Initiation of this trial has been delayed due to manufacturing issues, and it is not expected to be initiated until after the third quarter of 2013, according to an Imprimis Pharmaceuticals media release.
    • 22 Jul 2013 Imprimis has received IRB approval for this trial, engaged Agility Clinical to conduct it, and expects to commence it in the third quarter of 2013, according to an Imprimis Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top